PD-L1 testing in urothelial carcinoma: are we there yet?

Cisplatinum-based chemotherapy is the standard treatment modality of patients with locally advanced or metastatic urothelial cell carcinoma. Due to its toxicity, however, a significant number of patients is ineligible for this treatment.